Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neurobiology of depression and novel antidepressant drug targets.

Current pharmaceutical design - 1 Jan 2012

Kern Nikola, Sheldrick Abigail J, Schmidt Frank M, Minkwitz Juliane

Abstract excerpt

Depression is one of the most common psychiatric conditions affecting numerous individuals in the world. However, the currently available antidepressant medication shows low response and remission rates. Thus, new antidepressants need to be discovered or developed. Aiming to describe the current neurobiological hypotheses regarding the pathophysiology of depression and in order to give an overview of novel...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Brain
Share to Circadian Rhythm

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Depression

Share to Drug Design

Share to Epigenesis, Genetic

Share to Gene Expression Regulation

Share to Neurogenesis

Source

Identifiers

PMID: 22681160
DOI: 10.2174/138161212803523581

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neurobiology of depression and novel antidepressant drug targets.PMID 22681160Read ↗

Recent advances in depression research: from stress to molecular biology and brain imaging.Semantic proximity Read ↗

The neurobiology of depression—revisiting the serotonin hypothesis. I. Cellular and molecular mechanismsSemantic proximity Read ↗

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets.Semantic proximity Read ↗

Epigenetics, depression and antidepressant treatment.Semantic proximity Read ↗

Dysregulation of brain dopamine systems in major depressive disorderSemantic proximity Read ↗

The neurobiology of depression—revisiting the serotonin hypothesis. II. Genetic, epigenetic and clinical studies <sup/>Semantic proximity Read ↗

The neurobiology of depression.Semantic proximity Read ↗

Epigenetic Modulation of Mood DisordersSemantic proximity Read ↗

Epigenetic mechanisms underlying the role of brain-derived neurotrophic factor in depression and response to antidepressants.Semantic proximity Read ↗

[Neural plasticity mechanism of depression].Semantic proximity Read ↗

Epigenetic mechanisms of depression.Semantic proximity Read ↗

Treatment-resistant depression: molecular mechanisms and managementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.